The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that
class action litigation has been brought on behalf of those who
purchased or otherwise acquired the securities of Impax Laboratories,
Inc. (“Impax” or the “Company”) (NasdaqGS: IPXL) between May 20, 2013
and July 28, 2014, inclusive (the “Class Period”).
If you purchased or otherwise acquired Impax securities during the Class
Period, you may move the Court for appointment as lead plaintiff by no
later than October 13, 2014.
for Lieff Cabraser Announces Class Action Litigation Against Impax Laboratories, Inc. - IPXL investment picks